Gryrotonic Training in Behcet-diseased Elders With Breast Cancer
NCT07929116, Not applicable, Recruiting, Cairo University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Gryrotonic Training in Behcet-diseased Elders With Breast Cancer | ClinicalTrials.gov |
| NCT number | NCT07929116 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 40 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Cairo University | ClinicalTrials.gov |
| Conditions | Breast Cancer, Behcet Disease | ClinicalTrials.gov |
| Interventions | exercise | ClinicalTrials.gov |
| First posted | 2026-11-10 | ClinicalTrials.gov |
| Last updated | 2026-11-10 | ClinicalTrials.gov |
Registered outcomes 30
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Short Physical Performance Battery | it will be measured after 12 weeks | the total score will be calcualted | ClinicalTrials.gov |
| Secondary | Dual task gait speed | It will be measured after 12 weeks | this task assess gait speed | ClinicalTrials.gov |
| Secondary | Four-square step test | It will be measured after 12 weeks | it is fucntional balnce test | ClinicalTrials.gov |
| Secondary | grip strenghts | It will be measured after 12 weeks | it is a measure of grip strenghths in dominant hand | ClinicalTrials.gov |
| Secondary | time up- and go testing | It will be measured after 12 weeks | it is a measure of fall risk | ClinicalTrials.gov |
| Secondary | sit-to-stand 30-second testing | It will be measured after 12 weeks | asess number of repteations of sit-to-staning in 30 seconds | ClinicalTrials.gov |
| Secondary | six minute walking testingg | It will be measured after 12 weeks | distance covered by subject in six minutes wil be assessed | ClinicalTrials.gov |
| Secondary | 10-meters walking testing | It will be measured after 12 weeks | time covered for walking for ten meter will be assessed | ClinicalTrials.gov |
| Secondary | trunk-flexor McGill core endurance test | It will be measured after 12 weeks | this test will assess endurance of trunk flexors | ClinicalTrials.gov |
| Secondary | trunk-extensor McGill core endurance test | It will be measured after 12 weeks | this test will assess endurance of trunk extensors | ClinicalTrials.gov |
| Secondary | right-lateral-trunk-bending McGill core endurance test | It will be measured after 12 weeks | this test will assess endurance of right lateral trunk bendors | ClinicalTrials.gov |
| Secondary | left-lateral-trunk-bending McGill core endurance test | It will be measured after 12 weeks | this test will assess endurance of left lateral trunk bendors | ClinicalTrials.gov |
| Secondary | arm flexion in thrity seconds | It will be measured after 12 weeks | it will assess numbers (repeations) of arm flexion in thirty second | ClinicalTrials.gov |
| Secondary | maximal nubmer of push up | It will be measured after 12 weeks | this will assess maximal number of performed psh ups in speciifc time | ClinicalTrials.gov |
| Secondary | behcet disease quality of life | It will be measured after 12 weeks | questioanire that will assess life quality in behcet disease (total score will be estiamted) | ClinicalTrials.gov |
| Secondary | total score of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30 | It will be measured after 12 weeks | it is a questioaire asess quality of life | ClinicalTrials.gov |
| Secondary | physical fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30 | It will be measured after 12 weeks | it is a questioaire asess physical fucntion related quality of life | ClinicalTrials.gov |
| Secondary | role fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30 | It will be measured after 12 weeks | it is a questioaire asess role fucntion related quality of life | ClinicalTrials.gov |
| Secondary | emotional fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30 | It will be measured after 12 weeks | it is a questioaire asess emotional fucntion related quality of life | ClinicalTrials.gov |
| Secondary | cognitive fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30 | It will be measured after 12 weeks | it is a questioaire asess cognitive fucntion related quality of life | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)